Two Sides of the Same Ecosystem.

One Partner for Both.


Whether you're building a company or backing one, the science and the regulation behind it have to hold up under scrutiny.

Too much of that risk surfaces late, after a term sheet is signed, or after a regulatory submission stalls.

PLG brings the same expertise that supports the world's largest pharmaceutical companies to the moments that matter most for startups and investors alike.



For Startups

Early-stage Biotech, MedTech, and digital health companies face outsized regulatory and scientific hurdles with limited internal resources.

As a Privileged Partner of EIT Health's Venture Centre of Excellence, PLG helps startups build a credible, de-risked pathway to market — turning regulatory readiness into a competitive advantage when raising capital.

Learn more about our Startup support

 

For Investors

Venture capital and private equity firms evaluating life sciences targets need more than financial due diligence. PLG supports investors with commercial, regulatory, and manufacturing due diligence, from target screening through post-merger integration.

Learn more about our Investor services

For Startups. For Investors.

 

Whether you're building a company or evaluating one, the path forward depends on getting the regulatory and commercial fundamentals right from the start.

Explore how PLG supports each side, from early-stage development to investment-grade due diligence.

1_Specialized-consultants-or-scientists-in-regulatory-activities-1920x900-1
Startup Regulatory & Innovation Support

A de-risked, credible regulatory pathway to market for early-stage Biotech, MedTech, and digital health companies preparing to raise their next round.

next-arrow
1_Investment Due Diligence Services
Investment Due Diligence Services

Independent commercial, regulatory, and manufacturing due diligence for life sciences deals, from target screening through post-merger integration.

arrow

Frequently asked questions

PLG helps early-stage biotech, MedTech and digital health companies build a credible, de-risked regulatory pathway to market. A clear regulatory strategy reduces development risk and becomes a competitive advantage when raising capital. Startups get access to the same expertise PLG provides to the world's largest pharmaceutical companies. See Startup Regulatory & Innovation Support.

PLG is a Privileged Partner of EIT Health's Venture Centre of Excellence, which supports European health startups on their path to market and investment. Through this partnership, PLG provides regulatory expertise to help early-stage companies build the regulatory pathway their next funding round depends on.

Investors increasingly assess whether the regulatory pathway behind a product will hold up, not only the science. A documented strategy, with a clear classification, development plan and agency interactions, shortens due diligence and reduces the discount investors apply for regulatory risk. It also helps avoid stalled submissions after funding.

PLG provides independent commercial, regulatory and manufacturing due diligence for life sciences deals. It serves venture capital, private equity and life sciences companies, from target screening through to post-merger integration. See Investment Due Diligence Services.

It assesses whether the target's products, approvals and pipeline are what they appear to be. This typically covers the regulatory pathway and timelines, the quality of submissions and agency interactions, compliance history, and pharmacovigilance and quality systems. The output is a clear view of risks that may affect value or deal terms.

Yes. PLG supports post-merger integration, including alignment of regulatory, quality and safety systems and migration of data into compliant repositories. Because PLG also delivers these services operationally, investors can move from assessment to execution with the same team.

Yes. PLG supports startups in biotech, MedTech and digital health. Each has its own regulatory framework, from medicinal product pathways to device classification and software as a medical device, and PLG adapts its support to the product and the company's stage of growth.